openPR Logo

Press Releases from DelveInsight Business Research (5409 total)

Chronic Refractory Cough Pipeline Drugs Analysis Report (2024 Updates): FDA Appr …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Refractory Cough pipeline constitutes key companies continuously working towards developing Chronic Refractory Cough

Congenital Hyperinsulinism Pipeline Drugs Analysis Report: FDA Approvals, Clinic …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Congenital Hyperinsulinism pipeline constitutes 4+ key companies continuously working towards developing 6+ Congenital Hyperinsulinism

IgA Nephropathy Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, IgA Nephropathy pipeline constitutes 30+ key companies continuously working towards developing 25+ IgA Nephropathy

Myasthenia Gravis Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Tri …

(Albany, USA) As per DelveInsight's assessment, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Myasthenia Gravis therapeutics landscape

Neuronal Ceroid-Lipofuscinoses Market Forecast 2032: FDA, EMA, PDMA Approvals, C …

(Albany, USA) DelveInsight's "Neuronal Ceroid-Lipofuscinoses (CLN1 disease) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Neuronal Ceroid-Lipofuscinoses (CLN1 disease), historical and

ALK-positive Non-Small Cell Lung Cancer (NSCLC) Pipeline Analysis 2024: FDA Appr …

(Albany, USA) As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the ALK-positive Non-Small Cell

Microsatellite Stable Colorectal Cancer Pipeline Analysis 2024: FDA Approvals, C …

(Albany, USA) As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Microsatellite Stable Colorectal

Galactosemia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, …

(Albany, USA) As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Galactosemia therapeutics landscape

Alzheimer's Disease Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Alzheimer's Disease pipeline constitutes 150+ key companies continuously working towards developing 160+ Alzheimer's Disease

Cognitive Impairment Associated with Schizophrenia Pipeline Drugs Analysis Repor …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cognitive Impairment Associated with Schizophrenia pipeline constitutes 5+ key companies continuously working towards developing

Cancer Vaccines Competitive Landscape and Drugs Analysis Report, 2023: FDA Appro …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cancer Vaccines pipeline constitutes 250+ key companies continuously working towards developing 300+ Cancer Vaccines

Myotonic Dystrophy Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myotonic Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy

Treg Cell-Based Therapies Pipeline Analysis, 2024 Updates | Latest FDA, EMA, and …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Treg Cell-Based Therapies pipeline constitutes key companies continuously working towards developing Treg Cell-Based Therapies

Genital Herpes Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Ther …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Genital Herpes pipeline constitutes key companies continuously working towards developing Genital Herpes treatment therapies,

Non-Cystic Fibrosis Bronchiectasis Pipeline Drugs Analysis Report, 2024 Updates: …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Non-Cystic Fibrosis Bronchiectasis pipeline constitutes 16+ key companies continuously working towards developing 17+ Non-Cystic

Chronic Rhinosinusitis with Nasal Polyps Pipeline Analysis 2024: FDA Approvals, …

(Albany, USA) As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Chronic Rhinosinusitis with

Advanced Ovarian Cancer Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical …

As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Advanced Ovarian Cancer therapeutics landscape

Angio-immunoblastic T-cell Lymphoma Market Forecast 2032: FDA, EMA, PDMA Approva …

(Albany, USA) DelveInsight's "Angio-immunoblastic T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Angio-immunoblastic T-cell Lymphoma, historical and forecasted epidemiology

Hemophagocytic Lymphohistiocytosis Market Forecast 2032: FDA, EMA, PDMA Approval …

(Albany, USA) DelveInsight's "Hemophagocytic Lymphohistiocytosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hemophagocytic Lymphohistiocytosis, historical and forecasted epidemiology as well

Hypercholesterolaemia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Th …

(Albany, USA) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Hypercholesterolaemia therapeutics landscape

Charcot Marie Tooth Disease Pipeline Drugs Analysis Report (2024 Updates): FDA A …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Charcot Marie Tooth Disease pipeline constitutes 10+ key companies continuously working towards developing 10+

Chronic Kidney Disease Pipeline Drugs Analysis Report, 2024 Updates: FDA Approva …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Kidney Disease pipeline constitutes 76+ key companies continuously working towards developing 80+ Chronic

Prostate Cancer Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Cl …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Prostate Cancer pipeline constitutes 140+ key companies continuously working towards developing 150+ Prostate Cancer

Influenza Pipeline Assessment, 2024 Updates: FDA, EMA, and PMDA Approvals, Emerg …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Influenza pipeline constitutes 120+ key companies continuously working towards developing 120+ Influenza treatment therapies,

Mucopolysaccharidosis Type I Pipeline Drugs Analysis Report, 2024: FDA Approvals …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Mucopolysaccharidosis Type I pipeline constitutes 12+ key companies continuously working towards developing 12+ Mucopolysaccharidosis

HER2 Negative Breast Cancer Pipeline Drugs Analysis Report, 2024: FDA Approvals, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, HER2 Negative Breast Cancer pipeline constitutes 70+ key companies continuously working towards developing 75+

Colorectal Cancer Pipeline and Clinical Trials Assessment 2024: FDA Approvals, T …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Colorectal Cancer pipeline constitutes 195+ key companies continuously working towards developing 200+ Colorectal Cancer

Diabetic Kidney Disease market size was USD 7.2 billion in 2023, estimates Delve …

(Albany, USA) DelveInsight's Diabetic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, diabetic kidney disease emerging drugs, market share of

Motor Neuron Disease Pipeline Analysis 2024: FDA Approvals, Clinical Trials, The …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Motor Neuron Disease pipeline constitutes 180+ key companies continuously working towards developing 200+ Motor Neuron

Graves Disease Pipeline Assessment 2024 (Updates): EMA, PDMA, FDA Approvals, Cli …

As per DelveInsight's assessment, globally, Graves Disease pipeline constitutes 8+ key companies continuously working towards developing 10+ Graves Disease treatment therapies, analysis of Clinical Trials,

Pancreatic Cancer Pipeline Assessment 2024 (Updates): EMA, PDMA, FDA Approvals, …

(Albany, USA) As per DelveInsight's assessment, globally, about 290+ key pharma and biotech companies are working on 300+ pipeline drugs in the Pancreatic Cancer therapeutics

Myelodysplastic Syndrome Pipeline Assessment 2024 (Updates): EMA, PDMA, FDA Appr …

Myelodysplastic Syndrome companies are Novartis, Syros Pharmaceuticals, Curis, Ryvu Therapeutics, Chia Tai Tianqing Pharmaceutical Group, Amgen, Sanofi, Forma Therapeutics, Agios Pharmaceuticals, AbbVie, Daiichi Sankyo Company,

Follicular Lymphoma Pipeline Analysis, 2024 Updates | Latest FDA, EMA, and PMDA …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Follicular Lymphoma pipeline constitutes 50+ key companies continuously working towards developing 50+ Follicular Lymphoma

Crohn's Disease Pipeline and Clinical Trials Assessment 2024: FDA Approvals, The …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Crohn's Disease pipeline constitutes 90+ key companies continuously working towards developing 90+ Crohn's Disease

Hypoxia Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical T …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hypoxia pipeline constitutes key companies continuously working towards developing Hypoxia treatment therapies, analysis of

DUB Inhibitors Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Cli …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, DUB Inhibitors pipeline constitutes key companies continuously working towards developing DUB Inhibitors treatment therapies,

Polymyositis Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trial …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Polymyositis pipeline constitutes 7+ key companies continuously working towards developing 7+ Polymyositis treatment therapies,

Toll Like Receptor agonists Pipeline and Clinical Trials Assessment 2024: FDA Ap …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Toll Like Receptor agonists pipeline constitutes 60+ key companies continuously working towards developing 60+

Knee Osteoarthritis Pipeline Assessment, 2024 Updates: FDA, EMA, and PMDA Approv …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Knee Osteoarthritis pipeline constitutes 40+ key companies continuously working towards developing 40+ Knee Osteoarthritis

Graves Disease Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Cli …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Graves Disease pipeline constitutes 8+ key companies continuously working towards developing 10+ Graves Disease

Thrombotic Thrombocytopenic Purpura Market to Observe Impressive Growth During t …

DelveInsight's "Thrombotic Thrombocytopenic Purpura Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Thrombotic Thrombocytopenic Purpura, historical and forecasted epidemiology as

Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth Durin …

DelveInsight's "Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Atherosclerotic Cardiovascular Disease, historical and forecasted epidemiology

Postpartum Depression Market and Epidemiology Forecast 2032: Population Data, Dr …

DelveInsight's "Postpartum Depression Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Postpartum Depression, historical and forecasted epidemiology as well as

Fabry Disease Market to Observe Impressive Growth During the Forecast Period (20 …

DelveInsight's "Fabry Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Fabry Disease, historical and forecasted epidemiology as well as

Graft-Versus-Host Disease Market 2032: Epidemiology Analysis, Therapeutic Advanc …

The Graft-Versus-Host Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Graft-Versus-Host

Vasculitis Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapie …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Vasculitis pipeline constitutes 20+ key companies continuously working towards developing 30+ Vasculitis treatment therapies,

PD-1 Non-Small Cell Lung Cancer Pipeline Drugs Analysis Report, 2024 Updates: FD …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PD-1 Non-Small Cell Lung Cancer pipeline constitutes 30+ key companies continuously working towards developing

Necrotizing Enterocolitis Pipeline and Clinical Trials Assessment, 2024 Updates: …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Necrotizing Enterocolitis pipeline constitutes 4+ key companies continuously working towards developing 4+ Necrotizing Enterocolitis

Hepatocellular Carcinoma Pipeline Analysis 2024: FDA Approvals, Clinical Trials, …

(Albany, USA) As per DelveInsight's assessment, globally, about 90+ key pharma and biotech companies are working on 95+ pipeline drugs in the Hepatocellular Carcinoma therapeutics

Gastrointestinal Stromal Tumor (GIST) Pipeline Analysis 2024: FDA Approvals, Cli …

(Albany, USA) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 28+ pipeline drugs in the Gastrointestinal Stromal Tumor

Go To Page:    41 42 43 44 45 46 47 48 49 50